Registered entities
Oncoimmune, Inc.
Reg. No. 6521145United States
Innovation
21 patent families (10 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 904 times.
| Year | Filings |
|---|---|
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 10 |
| 2019 | 14 |
| 2020 | 17 |
| 2021 | 15 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Investor mix
7 investors on record; lead investors include Kaitai Capital Management, GBA Capital, GF Xinde Investment Management; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Accelerator & incubator | 2 | 29% |